Merial has launched a limited trial pack version of Equioxx^® (firocoxib), the company's COX-2 specific NSAID for horses, which contains 10 tubes of the oral paste.

According to the company, Equioxx is the only equine NSAID that is highly COX-2 selective, acting to reduce pain and inflammation whilst preserving the natural physiological effects of the COX-1 enzyme, at therapeutic levels.

The company also claims that field studies have confirmed that firocoxib is highly effective at controlling pain and improving function in horses with chronic osteoarthritis.

Jim Tipp BVSc MRCVS, partner at Shropshire based Fyrnwy Equine Clinics said: "As a COX-2 specific NSAID it is not only a good analgesic, but is also an excellent anti-inflammatory. In addition, the COX-1 sparing properties of Equioxx are beneficial where there is increased risk of ulceration."

Equioxx is also available as a low dose injectable solution. For more information contact Merial Customer Services on 0870 6000 123.

PS: Whilst you're here, take a moment to see our latest job opportunities for vets.